A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease
Clinical trial NCT00207766 · COMPLETED
Trial details
- NCT number
- NCT00207766
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-06-01
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.